Fluorescence imaging of tumor immune contexture in immune checkpoint blockade therapy
- 11 February 2022
- journal article
- research article
- Published by Elsevier BV in International Immunopharmacology
- Vol. 106, 108617
- https://doi.org/10.1016/j.intimp.2022.108617
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysisBMC Cancer, 2014
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerThe New England Journal of Medicine, 2012
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerThe New England Journal of Medicine, 2012
- Radiomics: Extracting more information from medical images using advanced feature analysisEuropean Journal of Cancer, 2012
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune EscapeScience Translational Medicine, 2012
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumorsProceedings of the National Academy of Sciences of the United States of America, 2012
- Cancer cell–selective in vivo near infrared photoimmunotherapy targeting specific membrane moleculesNature Medicine, 2011
- NIR dyes for bioimaging applicationsCurrent Opinion in Chemical Biology, 2010
- New Technologies for Human Cancer ImagingJournal of Clinical Oncology, 2008
- Photodynamic therapy and anti-tumour immunityNature Reviews Cancer, 2006